Cayman Chemical, an industry-leading supplier of bioactive lipids, analytical standards, and contract lipidomic services, announced today that it has acquired Matreya, LLC, a lipid biochemical company located in State College, Pennsylvania, with strengths in synthesis, extraction, and purification of natural products. Matreya stocks a wide selection of high-purity sphingolipids, phospholipids, fatty acids and esters, and sterols to be used as research standards.
Ann Arbor, MI, June 05, 2019 — Cayman Chemical, an industry-leading supplier of bioactive lipids, analytical standards, and contract lipidomic services, announced today that it has acquired Matreya, LLC, a lipid biochemical company located in State College, Pennsylvania, with strengths in synthesis, extraction, and purification of natural products. Matreya stocks a wide selection of high-purity sphingolipids, phospholipids, fatty acids and esters, and sterols to be used as research standards in biotechnology and pharmaceutical pursuits. They also offer antibodies to glycosphingolipids and inhibitors of enzymes involved in glycosphingolipid metabolism. “The addition of these products to the Cayman catalog provides valuable tools necessary to study the structure of cell membranes, growth regulators in cellular metabolism, and intracellular mediators,” said Dr. Kirk Maxey, President at Cayman Chemical. “We are pleased to continue to make these resources widely available to life science researchers.”
Following the transaction, Matreya will operate under their brand, continuing to offer high-quality products from their catalog, while maintaining the dedicated technical support, problem-solving know-how, and close working relationships that their customers have grown to rely upon. “Matreya is very excited to be part of a premier company like Cayman Chemical. This merger will allow Matreya products to be more visible and create new opportunities for global research in the area of lipid chemistry. The excellent product purity and prompt delivery we have offered for years will not change,” said Gary Walker, Vice President of Manufacturing and General Manager of Matreya. Stephen Barrett, Vice President of Chemistry at Cayman Chemical, further remarked that “the synergies accomplished through the joining of our talented and energetic research teams will greatly expand Cayman's lipids portfolio and accelerate the development of novel, high-value research tools and analytical standards. Our goal is to provide the most comprehensive lipid catalog to help make research possible.”
Terms of the transaction were not disclosed.
About Matreya, LLC
Matreya, LLC is committed to the development and manufacture of lipids and biochemicals of the highest quality and value. Their years of experience in chemical synthesis and in the extraction and purification of natural products allow them to achieve the best attainable purity using state-of-the-art techniques. Their product line includes a broad range of sphingolipids, glycolipids, glycosphingolipids, fatty acids and esters, sterols, and vitamin E isomers (tocopherols and tocotrienols). Matreya’s specialty is in producing high-purity sphingosines, ceramides, sulfatides, globotriaosylceramides, gangliosides, enzyme inhibitors, tocopherols, and tocotrienols. Within the area of sphingolipids, they have earned a reputation as the preferred problem solver and technology leader due to their dedicated technical assistance.
About Cayman Chemical
Cayman Chemical Company, Inc. helps make research possible by supplying scientists worldwide with biochemical tools used to understand cancer, neurochemistry, oxidative injury, endocrinology, atherosclerosis, and other human health challenges. Their scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others for use as research reagents and qualified standards. Cayman Chemical is also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination. In addition, they offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques. Cayman Chemical develops and manufactures active pharmaceutical ingredients (APIs) in both Ann Arbor, Michigan and Neratovice, Czech Republic at their Cayman Pharma facilities.
Powered by WPeMatico